Matches in SemOpenAlex for { <https://semopenalex.org/work/W2341506597> ?p ?o ?g. }
- W2341506597 endingPage "3704" @default.
- W2341506597 startingPage "3689" @default.
- W2341506597 abstract "Three series (6, 13, and 14) of new diarylaniline (DAAN) analogues were designed, synthesized, and evaluated for anti-HIV potency, especially against the E138K viral strain with a major mutation conferring resistance to the new-generation non-nucleoside reverse transcriptase inhibitor drug rilpivirine (1b). Promising new compounds were then assessed for physicochemical and associated pharmaceutical properties, including aqueous solubility, log P value, and metabolic stability, as well as predicted lipophilic parameters of ligand efficiency, ligand lipophilic efficiency, and ligand efficiency-dependent lipophilicity indices, which are associated with ADME property profiles. Compounds 6a, 14c, and 14d showed high potency against the 1b-resistant E138K mutated viral strain as well as good balance between anti-HIV-1 activity and desirable druglike properties. From the perspective of optimizing future NNRTI compounds as clinical trial candidates, computational modeling results provided valuable information about how the R(1) group might provide greater efficacy against the E138K mutant." @default.
- W2341506597 created "2016-06-24" @default.
- W2341506597 creator A5005512198 @default.
- W2341506597 creator A5007697812 @default.
- W2341506597 creator A5028253155 @default.
- W2341506597 creator A5030611592 @default.
- W2341506597 creator A5043836895 @default.
- W2341506597 creator A5045545412 @default.
- W2341506597 creator A5051426510 @default.
- W2341506597 creator A5067500491 @default.
- W2341506597 creator A5069302796 @default.
- W2341506597 creator A5069428613 @default.
- W2341506597 creator A5078423203 @default.
- W2341506597 creator A5080802367 @default.
- W2341506597 date "2016-04-12" @default.
- W2341506597 modified "2023-10-14" @default.
- W2341506597 title "Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus" @default.
- W2341506597 cites W1971297095 @default.
- W2341506597 cites W1971589868 @default.
- W2341506597 cites W1976163006 @default.
- W2341506597 cites W1978009405 @default.
- W2341506597 cites W1980901798 @default.
- W2341506597 cites W1991492628 @default.
- W2341506597 cites W1998698366 @default.
- W2341506597 cites W2002109109 @default.
- W2341506597 cites W2008525757 @default.
- W2341506597 cites W2040076362 @default.
- W2341506597 cites W2043448829 @default.
- W2341506597 cites W2046511427 @default.
- W2341506597 cites W2053570554 @default.
- W2341506597 cites W2062233777 @default.
- W2341506597 cites W2062458432 @default.
- W2341506597 cites W2063089952 @default.
- W2341506597 cites W2067125249 @default.
- W2341506597 cites W2069217314 @default.
- W2341506597 cites W2077945404 @default.
- W2341506597 cites W2084302660 @default.
- W2341506597 cites W2097626122 @default.
- W2341506597 cites W2105649494 @default.
- W2341506597 cites W2109193129 @default.
- W2341506597 cites W2109893413 @default.
- W2341506597 cites W2118649489 @default.
- W2341506597 cites W2119644971 @default.
- W2341506597 cites W2138237746 @default.
- W2341506597 cites W2139762361 @default.
- W2341506597 cites W2151569835 @default.
- W2341506597 cites W2394875150 @default.
- W2341506597 cites W2418625974 @default.
- W2341506597 doi "https://doi.org/10.1021/acs.jmedchem.5b01827" @default.
- W2341506597 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5206802" @default.
- W2341506597 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27070547" @default.
- W2341506597 hasPublicationYear "2016" @default.
- W2341506597 type Work @default.
- W2341506597 sameAs 2341506597 @default.
- W2341506597 citedByCount "30" @default.
- W2341506597 countsByYear W23415065972016 @default.
- W2341506597 countsByYear W23415065972017 @default.
- W2341506597 countsByYear W23415065972018 @default.
- W2341506597 countsByYear W23415065972019 @default.
- W2341506597 countsByYear W23415065972020 @default.
- W2341506597 countsByYear W23415065972021 @default.
- W2341506597 countsByYear W23415065972022 @default.
- W2341506597 countsByYear W23415065972023 @default.
- W2341506597 crossrefType "journal-article" @default.
- W2341506597 hasAuthorship W2341506597A5005512198 @default.
- W2341506597 hasAuthorship W2341506597A5007697812 @default.
- W2341506597 hasAuthorship W2341506597A5028253155 @default.
- W2341506597 hasAuthorship W2341506597A5030611592 @default.
- W2341506597 hasAuthorship W2341506597A5043836895 @default.
- W2341506597 hasAuthorship W2341506597A5045545412 @default.
- W2341506597 hasAuthorship W2341506597A5051426510 @default.
- W2341506597 hasAuthorship W2341506597A5067500491 @default.
- W2341506597 hasAuthorship W2341506597A5069302796 @default.
- W2341506597 hasAuthorship W2341506597A5069428613 @default.
- W2341506597 hasAuthorship W2341506597A5078423203 @default.
- W2341506597 hasAuthorship W2341506597A5080802367 @default.
- W2341506597 hasBestOaLocation W23415065972 @default.
- W2341506597 hasConcept C104317684 @default.
- W2341506597 hasConcept C142462285 @default.
- W2341506597 hasConcept C143065580 @default.
- W2341506597 hasConcept C156719811 @default.
- W2341506597 hasConcept C159047783 @default.
- W2341506597 hasConcept C178790620 @default.
- W2341506597 hasConcept C185592680 @default.
- W2341506597 hasConcept C201399114 @default.
- W2341506597 hasConcept C202751555 @default.
- W2341506597 hasConcept C2777351918 @default.
- W2341506597 hasConcept C2777752112 @default.
- W2341506597 hasConcept C2778484023 @default.
- W2341506597 hasConcept C2778723075 @default.
- W2341506597 hasConcept C2909970146 @default.
- W2341506597 hasConcept C2993143319 @default.
- W2341506597 hasConcept C3013748606 @default.
- W2341506597 hasConcept C55493867 @default.
- W2341506597 hasConcept C57992300 @default.
- W2341506597 hasConcept C67705224 @default.
- W2341506597 hasConcept C69366308 @default.
- W2341506597 hasConcept C71240020 @default.